DEXAMETHASONE
DISSEMINATED TUBERCULOSIS·+61
ROXANE LABS.
Indication
Burkitt's lymphoma
Burkitt's lymphoma is an aggressive, rapidly proliferating form of mature B-cell non-Hodgkin lymphoma that primarily involves the lymphatic and hematologic systems. Read more about Burkitt's lymphoma
182 drugs 116 manufacturers
Drugs that treat it
Common Burkitt's lymphoma therapies.
DEXAMETHASONE
DISSEMINATED TUBERCULOSIS·+61
ROXANE LABS.
CYCLOPHOSPHAMIDE
NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
Baxter Healthcare Company
DEXAMETHASONE INTENSOL (dexamethasone)
DISSEMINATED TUBERCULOSIS·+61
ROXANE LABS.
DOXORUBICIN HCL
ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
SUN PHARMACEUTI
DOXORUBICIN HCL
ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Laboratories Div
DOXORUBICIN HCL
OSTEOSARCOMA OF BONE·+19
AMNEAL-AGILA, L
METHOTREXATE SODIUM (methotrexate sodium/PF)
OSTEOSARCOMA OF BONE·+12
Laboratories Div
DOXORUBICIN HCL
ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Burkitt's lymphoma preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonBurkitt's lymphoma is an aggressive, rapidly proliferating form of mature B-cell non-Hodgkin lymphoma that primarily involves the lymphatic and hematologic systems.
It is pathologically characterized by the translocation and deregulation of the *MYC* oncogene on chromosome 8, leading to extremely high rates of cellular proliferation and a classic "starry-sky" histologic appearance.
The malignancy presents in three epidemiological clinical variants—endemic, sporadic, and immunodeficiency-associated—frequently affecting children, young adults, and individuals with HIV or other immunocompromised states.
Patients commonly present with acute, rapidly enlarging extranodal tumor masses involving the jaw and facial bones, abdomen, gastrointestinal tract, central nervous system, or bone marrow.
- cancer.gov
Burkitt's lymphoma is an aggressive, rapidly proliferating form of mature B-cell non-Hodgkin lymphoma that primarily involves the lymphatic and hematologic systems The malignancy presents in three epidemiological clinical variants—endemic, sporadic, and immunodeficiency-associated—frequently affecting children, young adults, and individuals with HIV or other immunocompromised states Patients commonly present with acute, rapidly enlarging extranodal tumor masses involving the jaw and facial bones...
- nih.gov
Burkitt's lymphoma is an aggressive, rapidly proliferating form of mature B-cell non-Hodgkin lymphoma that primarily involves the lymphatic and hematologic systems It is pathologically characterized by the translocation and deregulation of the *MYC* oncogene on chromosome 8, leading to extremely high rates of cellular proliferation and a classic "starry-sky" histologic appearance
- cancer.gov
It is pathologically characterized by the translocation and deregulation of the *MYC* oncogene on chromosome 8, leading to extremely high rates of cellular proliferation and a classic "starry-sky" histologic appearance
- nih.gov
It is pathologically characterized by the translocation and deregulation of the *MYC* oncogene on chromosome 8, leading to extremely high rates of cellular proliferation and a classic "starry-sky" histologic appearance
Personalize your experience
Follow Burkitt's lymphoma and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.